Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$0.75 - $1.29 $1,994 - $3,430
-2,659 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$0.33 - $1.62 $19 - $97
-60 Reduced 2.21%
2,659 $3,000
Q4 2019

Feb 04, 2020

SELL
$1.23 - $2.67 $301 - $654
-245 Reduced 8.27%
2,719 $3,000
Q3 2019

Nov 12, 2019

BUY
$1.25 - $5.0 $3,705 - $14,820
2,964 New
2,964 $6,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.